Plus Therapeutics reported $8.57M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Baxter International USD 3.81B 218M Sep/2026
Cerus USD 100.8M 12.37M Dec/2025
Dr.Reddys Laboratories INR 154.3B 3.04B Sep/2026
Haemonetics USD 300.84M 37.6M Sep/2026
Northwest Biotherapeutics USD 82.97M 4.93M Mar/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Sanofi EUR 29.77B 2.16B Sep/2026
Starpharma Holdings AUD 4.61M 614K Dec/2025
Sun Pharmaceuticals INR 235.92B 9.7B Sep/2026
Teva Pharmaceutical Industries USD 15.42B 221M Sep/2026